Pharmacy Biotechnology
Overview of the sector
  • France, ranked 3rd in Europe for biotechnology
  • France, 7th in the world for biotechnology
  • 100 companies
  • 5,000 jobs in Pharmaceuticals, Biotechnology/Biomedical


Fouad BOUNOUIDRATE
Take Contact

R&D a prime concern


Nutrition / Health with the Vitagora Competitive Cluster
    • Metabolic syndrome - cancer - diabetes - obesity – immunity
    • 4 major themes: Lifelong taste – Taste and lipid nutrition – Formulation, Processes and Materials – Preparation of raw materials
    • Collaboration with the ’Gerontopole’ on the application of taste amongst senior citizens

Pharmacological Imagery with GIE Pharm’image (Therapeutic Diagnosis – Targeted therapy)

    • Development of new experimental models and new biomarkers (CHU, CGFL, Oncodesign)
    • Development of new chemical tracers, hot and cold (ICMUB, ICB, Chematech)
    • Development of micro and nano technologies for tracers and contrast agents (ICB)
    • Development of a system of acquisition, storage and analysis of images (LE2I, CCITI)

Handicap-Mobility with the ‘gérontopôle’ and Welience Santé

    • 95 researchers spread between 5 research units
    • Work on the causes of motor dysfunction
    • 3 axes of development: neuroscience – physiology – biomechanics
    • Collaboration with the ‘gérontopôle’ on 2 axes: retraining of elderly persons – muscular re-education
    • Experts in bio-mechanics imaging
    • Geographically centralised at Dijon

The PARI (Regional Action Plan for Innovation) of the Burgundy Regional Council: an envelope of €10 M voted on 29 June 2009 to stimulate innovation by research in Burgundy industries.

Do you have a project in Burgundy? Burgundy Development Agency undertakes to put you in contact with its R&D and innovation partners.


 

- 5, Avenue Garibaldi - 21000 Dijon - France [Map] Tel: +33 (0)3.80.28.55.66 - Fax: +33 (0)3.80.28.77.66 - [contact@bourgognedeveloppement.com] -